Adagrasib in Non-Small-Cell Lung Cancer. Reply

N Engl J Med. 2022 Sep 29;387(13):1238-1239. doi: 10.1056/NEJMc2210539.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acetonitriles
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Humans
  • Lung Neoplasms* / genetics
  • Mutation
  • Piperazines
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Pyrimidines

Substances

  • Acetonitriles
  • KRAS protein, human
  • Piperazines
  • Pyrimidines
  • adagrasib
  • Proto-Oncogene Proteins p21(ras)